
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER LOCALIZED NEAR THE ALLOGRAFT IN RENAL TRANSPLANTATION
Author(s) -
Clifton E. Kew,
Robert LopezBen,
Jon Smith,
Michelle L. Robbin,
William J. Cook,
Robert S. Gaston,
Mark H. Deierhoi,
Bruce A. Julian
Publication year - 2000
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200003150-00023
Subject(s) - medicine , transplantation , immunosuppression , complication , nephrectomy , hydronephrosis , surgery , post transplant lymphoproliferative disorder , retrospective cohort study , kidney transplantation , kidney , lymphoma , rituximab , urinary system
Posttransplant lymphoproliferative disorder (PTLD), a complication of immunosuppression, develops in approximately 1% of renal allograft recipients. Typically, PTLD is a proliferation of B-cells associated with Epstein-Barr virus (EBV) infection; it is said to be most often a systemic disease. Involvement occasionally is localized near the allograft.